181 related articles for article (PubMed ID: 37248986)
1. [Research progress of sarcopenic obesity and chronic liver disease].
Tang LY; Zhou LZ; Zhang P
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):445-448. PubMed ID: 37248986
[TBL] [Abstract][Full Text] [Related]
2. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenic obesity: Time to meet the challenge.
Barazzoni R; Bischoff SC; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
Clin Nutr; 2018 Dec; 37(6 Pt A):1787-1793. PubMed ID: 29857921
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenic Obesity Is a Risk Factor for Worse Oncological Long-Term Outcome in Locally Advanced Rectal Cancer Patients: A Retrospective Single-Center Cohort Study.
Tschann P; Weigl MP; Clemens P; Szeverinski P; Attenberger C; Kowatsch M; Jäger T; Emmanuel K; Brock T; Königsrainer I
Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299595
[TBL] [Abstract][Full Text] [Related]
5. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
[TBL] [Abstract][Full Text] [Related]
6. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
8. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
[TBL] [Abstract][Full Text] [Related]
9. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
11. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
[TBL] [Abstract][Full Text] [Related]
12. Differences in body composition and physical function related to pure sarcopenia and sarcopenic obesity: A study of community-dwelling older adults in Japan.
Kera T; Kawai H; Hirano H; Kojima M; Fujiwara Y; Ihara K; Obuchi S
Geriatr Gerontol Int; 2017 Dec; 17(12):2602-2609. PubMed ID: 28657168
[TBL] [Abstract][Full Text] [Related]
13. Associations of sarcopenic obesity versus sarcopenia alone with functionality.
Bahat G; Kilic C; Ozkok S; Ozturk S; Karan MA
Clin Nutr; 2021 May; 40(5):2851-2859. PubMed ID: 33940398
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis.
Hara N; Iwasa M; Sugimoto R; Mifuji-Moroka R; Yoshikawa K; Terasaka E; Hattori A; Ishidome M; Kobayashi Y; Hasegawa H; Iwata K; Takei Y
Intern Med; 2016; 55(8):863-70. PubMed ID: 27086797
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenic Obesity: Time to Meet the Challenge.
Barazzoni R; Bischoff S; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
Obes Facts; 2018; 11(4):294-305. PubMed ID: 30016792
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III.
Batsis JA; Mackenzie TA; Barre LK; Lopez-Jimenez F; Bartels SJ
Eur J Clin Nutr; 2014 Sep; 68(9):1001-7. PubMed ID: 24961545
[TBL] [Abstract][Full Text] [Related]
17. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.
Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S
Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512
[TBL] [Abstract][Full Text] [Related]
18. Gamma-glutamyl transferase is associated with sarcopenia and sarcopenic obesity in community-dwelling older adults: results from the Fifth Korea National Health and Nutrition Examination Survey, 2010-2011.
Hong N; Lee EY; Kim CO
Endocr J; 2015; 62(7):585-92. PubMed ID: 25913781
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review.
Evans K; Abdelhafiz D; Abdelhafiz AH
Postgrad Med; 2021 Nov; 133(8):831-842. PubMed ID: 34126036
[TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease and high eGFR according to body composition phenotype in adults with normal BMI.
Hyun YY; Lee KB; Rhee EJ; Park CY; Chang Y; Ryu S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1088-1095. PubMed ID: 27776918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
